Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Raj Shah

Concepts (348)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cholangiopancreatography, Endoscopic Retrograde
45
2025
209
10.180
 Why?
Endoscopy, Digestive System
22
2024
135
6.390
 Why?
Pancreatic Ducts
22
2024
79
6.260
 Why?
Pancreatic Diseases
14
2024
66
4.870
 Why?
Pancreatitis, Chronic
12
2024
59
4.580
 Why?
Calculi
8
2022
16
3.980
 Why?
Bile Duct Neoplasms
13
2021
115
3.500
 Why?
Endosonography
25
2024
152
3.450
 Why?
Lithotripsy
11
2024
46
3.280
 Why?
Stents
20
2024
526
3.150
 Why?
Cholangitis, Sclerosing
8
2022
56
2.880
 Why?
Pancreatic Neoplasms
20
2024
859
2.640
 Why?
Cholangiocarcinoma
7
2021
93
2.510
 Why?
Drainage
10
2024
173
2.050
 Why?
Bile Ducts, Intrahepatic
5
2021
59
1.950
 Why?
Bile Ducts
9
2019
67
1.850
 Why?
Biliary Tract Surgical Procedures
4
2021
26
1.800
 Why?
Endoscopy, Gastrointestinal
12
2023
229
1.760
 Why?
Constriction, Pathologic
15
2022
238
1.660
 Why?
Pancreatic Pseudocyst
5
2024
17
1.300
 Why?
Gallstones
4
2018
33
1.290
 Why?
Microscopy, Confocal
8
2021
324
1.250
 Why?
Pancreas
6
2021
322
1.230
 Why?
Biliary Tract Diseases
4
2016
34
1.210
 Why?
Cholestasis
7
2021
208
1.120
 Why?
Endoscopes
3
2017
17
1.080
 Why?
Aged
51
2025
24186
1.020
 Why?
Middle Aged
59
2025
33811
1.000
 Why?
Carcinoma, Pancreatic Ductal
5
2016
267
1.000
 Why?
Treatment Outcome
30
2025
10930
0.960
 Why?
Adenocarcinoma
7
2023
885
0.890
 Why?
Retrospective Studies
30
2025
15919
0.880
 Why?
Pancreatitis
5
2024
133
0.870
 Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
7
2019
56
0.860
 Why?
Endoscopy
4
2015
320
0.860
 Why?
Endoscopes, Gastrointestinal
8
2013
13
0.850
 Why?
Common Bile Duct Neoplasms
1
2023
23
0.820
 Why?
Humans
108
2025
139072
0.820
 Why?
Duodenal Neoplasms
1
2023
24
0.820
 Why?
Ampulla of Vater
1
2023
34
0.820
 Why?
Choledochal Cyst
2
2020
17
0.810
 Why?
Laparoscopy
4
2021
454
0.800
 Why?
Hepatic Encephalopathy
1
2022
24
0.770
 Why?
Adenocarcinoma, Mucinous
2
2016
74
0.760
 Why?
Male
64
2025
68299
0.760
 Why?
Pancreatectomy
3
2021
244
0.760
 Why?
Gastrointestinal Tract
1
2025
203
0.750
 Why?
Catheterization
8
2024
182
0.750
 Why?
Female
66
2025
74071
0.750
 Why?
Portasystemic Shunt, Transjugular Intrahepatic
1
2022
36
0.740
 Why?
Cholangitis
1
2022
19
0.730
 Why?
Hypertension, Portal
1
2022
64
0.730
 Why?
Adenoma
2
2023
223
0.730
 Why?
End Stage Liver Disease
1
2022
72
0.700
 Why?
Cytodiagnosis
1
2020
32
0.650
 Why?
Calcinosis
2
2019
238
0.650
 Why?
Intestine, Small
2
2019
156
0.620
 Why?
In Situ Hybridization, Fluorescence
1
2020
310
0.600
 Why?
Adult
36
2025
38428
0.580
 Why?
Lithotripsy, Laser
2
2015
4
0.570
 Why?
Artificial Intelligence
1
2022
297
0.570
 Why?
Aged, 80 and over
18
2025
7686
0.570
 Why?
Quality of Life
4
2024
2962
0.560
 Why?
Aneurysm, False
1
2018
45
0.550
 Why?
Liver Neoplasms
1
2023
719
0.540
 Why?
Prospective Studies
23
2024
7666
0.530
 Why?
Foreign Bodies
1
2018
106
0.530
 Why?
Disposable Equipment
1
2017
21
0.530
 Why?
Laser Therapy
1
2018
127
0.510
 Why?
Biopsy
6
2018
1072
0.490
 Why?
Polyethylene
1
2016
17
0.480
 Why?
Gallbladder Diseases
1
2015
12
0.470
 Why?
Gastroenterology
4
2019
177
0.470
 Why?
Gastrointestinal Diseases
5
2022
208
0.450
 Why?
Pancreatic Juice
1
2014
2
0.450
 Why?
Learning Curve
5
2019
70
0.440
 Why?
Biomarkers, Tumor
2
2014
1229
0.440
 Why?
Sphincterotomy, Endoscopic
4
2019
28
0.430
 Why?
CA-19-9 Antigen
1
2014
27
0.430
 Why?
Metals
4
2023
140
0.420
 Why?
Postoperative Complications
3
2022
2721
0.420
 Why?
Sensitivity and Specificity
9
2021
1942
0.420
 Why?
Cholestasis, Intrahepatic
1
2013
29
0.400
 Why?
Hemorrhage
1
2018
747
0.390
 Why?
Ultrasonography, Interventional
3
2022
143
0.390
 Why?
Pancreatitis, Acute Necrotizing
2
2023
14
0.380
 Why?
Follow-Up Studies
12
2021
5153
0.370
 Why?
Predictive Value of Tests
7
2017
2032
0.370
 Why?
Liver Diseases
1
2014
290
0.360
 Why?
Anastomosis, Roux-en-Y
2
2022
26
0.350
 Why?
Young Adult
9
2025
13378
0.340
 Why?
Clinical Competence
5
2019
1151
0.330
 Why?
Biliary Tract Neoplasms
3
2016
29
0.330
 Why?
Foreign-Body Migration
2
2006
32
0.290
 Why?
Natural Orifice Endoscopic Surgery
3
2018
34
0.290
 Why?
Pancreatic Cyst
3
2018
48
0.280
 Why?
Needles
3
2019
61
0.280
 Why?
Gastrointestinal Hemorrhage
2
2008
130
0.280
 Why?
B7-1 Antigen
1
2008
58
0.280
 Why?
Video Recording
4
2016
181
0.280
 Why?
Fluorouracil
4
2020
204
0.260
 Why?
Bile Ducts, Extrahepatic
2
2020
18
0.260
 Why?
Gallbladder
2
2022
15
0.260
 Why?
Dilatation
2
2018
67
0.260
 Why?
Abdominal Pain
4
2023
142
0.250
 Why?
Adolescent
11
2025
21594
0.250
 Why?
Cholelithiasis
3
2015
37
0.240
 Why?
Autonomic Nerve Block
1
2024
10
0.230
 Why?
Celiac Plexus
1
2024
6
0.230
 Why?
Hemostatic Techniques
1
2005
49
0.220
 Why?
Indomethacin
1
2024
87
0.220
 Why?
Catheters
2
2015
73
0.220
 Why?
Peritoneal Neoplasms
1
2005
97
0.220
 Why?
Ambulatory Care Facilities
1
2006
246
0.210
 Why?
Guanidines
1
2023
41
0.210
 Why?
Tumor Suppressor Protein p53
1
2008
528
0.210
 Why?
Equipment Design
9
2013
518
0.210
 Why?
Esters
1
2023
77
0.200
 Why?
Cholecystitis, Acute
1
2022
23
0.190
 Why?
Self Expandable Metallic Stents
1
2022
16
0.190
 Why?
Prosthesis Implantation
2
2019
156
0.190
 Why?
Pain
3
2022
779
0.190
 Why?
Choledochostomy
1
2022
10
0.190
 Why?
Pain Measurement
1
2024
549
0.190
 Why?
Analgesics, Opioid
2
2024
1092
0.180
 Why?
Plastics
2
2022
50
0.180
 Why?
Multiple Myeloma
1
2005
272
0.180
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2024
358
0.180
 Why?
Multivariate Analysis
3
2021
1498
0.180
 Why?
Antimetabolites, Antineoplastic
2
2020
93
0.180
 Why?
Multicenter Studies as Topic
1
2022
321
0.170
 Why?
United States
9
2017
15078
0.170
 Why?
Tegafur
1
2020
6
0.170
 Why?
Lasers
1
2021
129
0.170
 Why?
Oxonic Acid
1
2020
8
0.170
 Why?
Dissection
2
2018
53
0.160
 Why?
Logistic Models
3
2021
2093
0.160
 Why?
Randomized Controlled Trials as Topic
4
2022
1523
0.160
 Why?
Living Donors
1
2022
272
0.160
 Why?
ROC Curve
2
2018
564
0.150
 Why?
Hydrogen Peroxide
1
2021
332
0.150
 Why?
Fiducial Markers
1
2019
9
0.150
 Why?
Urinary Calculi
1
2019
10
0.150
 Why?
Radiotherapy, Image-Guided
1
2019
34
0.150
 Why?
Severity of Illness Index
2
2022
2853
0.150
 Why?
Carcinoembryonic Antigen
2
2018
38
0.150
 Why?
Carcinoma, Squamous Cell
1
2004
638
0.150
 Why?
Reproducibility of Results
4
2019
3315
0.150
 Why?
Risk Factors
6
2024
10390
0.150
 Why?
Anastomosis, Surgical
1
2019
158
0.140
 Why?
Lasers, Solid-State
1
2018
22
0.140
 Why?
Journal Impact Factor
1
2018
28
0.140
 Why?
Cystadenoma, Serous
1
2018
18
0.140
 Why?
Cholecystectomy, Laparoscopic
1
2018
52
0.140
 Why?
Fiber Optic Technology
2
2015
23
0.140
 Why?
Gastric Outlet Obstruction
1
2017
12
0.140
 Why?
Hospitals, University
1
2018
175
0.140
 Why?
Diagnosis, Differential
3
2015
1482
0.130
 Why?
Neoplasm Recurrence, Local
1
2023
1058
0.130
 Why?
Parkinsonian Disorders
1
2017
43
0.130
 Why?
Urinary Incontinence
1
2017
65
0.130
 Why?
Gastrointestinal Neoplasms
2
2008
75
0.130
 Why?
Education, Medical, Graduate
2
2019
494
0.130
 Why?
Narrow Band Imaging
1
2016
14
0.130
 Why?
Feasibility Studies
4
2018
980
0.130
 Why?
Reoperation
1
2019
579
0.130
 Why?
Time Factors
3
2019
6869
0.120
 Why?
Neuroendocrine Tumors
1
2018
109
0.120
 Why?
Regression Analysis
1
2018
1021
0.120
 Why?
Gastric Bypass
1
2017
118
0.120
 Why?
Neoplasm Staging
6
2013
1374
0.120
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2016
26
0.120
 Why?
Cystadenoma, Mucinous
1
2015
10
0.120
 Why?
Cystadenocarcinoma, Mucinous
1
2015
11
0.120
 Why?
Periodicals as Topic
1
2018
211
0.120
 Why?
Pathology, Clinical
1
2015
29
0.120
 Why?
Radio Waves
1
2015
17
0.120
 Why?
Single-Blind Method
1
2016
287
0.110
 Why?
Fellowships and Scholarships
1
2019
310
0.110
 Why?
Pancreaticoduodenectomy
1
2016
127
0.110
 Why?
Incidence
2
2018
2832
0.110
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2013
1742
0.100
 Why?
Tertiary Care Centers
1
2014
169
0.100
 Why?
Fluoroscopy
3
2019
166
0.100
 Why?
Europe
1
2014
407
0.100
 Why?
Length of Stay
1
2019
1238
0.100
 Why?
Disinfection
2
2018
126
0.100
 Why?
Double-Balloon Enteroscopy
1
2013
1
0.100
 Why?
Databases, Factual
1
2018
1412
0.090
 Why?
Colonoscopy
2
2018
245
0.090
 Why?
Cyst Fluid
2
2018
21
0.090
 Why?
Catheter Ablation
1
2015
302
0.090
 Why?
Academic Medical Centers
2
2017
514
0.090
 Why?
Referral and Consultation
2
2016
795
0.090
 Why?
Technology Assessment, Biomedical
2
2008
40
0.090
 Why?
Chemoradiotherapy
1
2013
230
0.090
 Why?
Esophageal Neoplasms
2
2005
328
0.090
 Why?
Deoxycytidine
2
2013
192
0.090
 Why?
Carcinoma
1
2013
230
0.090
 Why?
Cohort Studies
2
2014
5749
0.090
 Why?
Parkinson Disease
1
2017
557
0.090
 Why?
Biopsy, Fine-Needle
2
2008
70
0.090
 Why?
Antibiotic Prophylaxis
1
2012
121
0.090
 Why?
Child
4
2018
21946
0.090
 Why?
Radiography
1
2013
841
0.080
 Why?
Practice Guidelines as Topic
1
2018
1570
0.080
 Why?
Minimally Invasive Surgical Procedures
2
2008
174
0.080
 Why?
Colorado
2
2018
4555
0.080
 Why?
Abdominal Abscess
1
2009
25
0.080
 Why?
Colonography, Computed Tomographic
1
2009
8
0.080
 Why?
Palliative Care
2
2009
815
0.080
 Why?
Risk Assessment
4
2016
3466
0.070
 Why?
Prognosis
3
2016
3999
0.070
 Why?
Capsule Endoscopy
1
2008
18
0.070
 Why?
Decompression, Surgical
1
2009
113
0.070
 Why?
Intestinal Perforation
1
2008
44
0.070
 Why?
Duodenum
1
2008
74
0.070
 Why?
Gastric Mucosa
1
2008
53
0.070
 Why?
V-Set Domain-Containing T-Cell Activation Inhibitor 1
1
2008
6
0.070
 Why?
Tissue Fixation
1
2008
37
0.070
 Why?
NAD(P)H Dehydrogenase (Quinone)
1
2008
33
0.070
 Why?
Balloon Occlusion
1
2008
35
0.070
 Why?
Equipment Safety
4
2008
37
0.070
 Why?
Wounds, Penetrating
1
2008
71
0.070
 Why?
Immunoenzyme Techniques
1
2008
209
0.070
 Why?
Medical Records Systems, Computerized
1
2008
95
0.070
 Why?
Coloring Agents
1
2007
95
0.070
 Why?
Radiotherapy, Intensity-Modulated
1
2008
137
0.070
 Why?
Image Enhancement
1
2008
191
0.060
 Why?
Rectal Neoplasms
1
2008
148
0.060
 Why?
Liver
2
2005
1807
0.060
 Why?
Duodenoscopy
1
2006
7
0.060
 Why?
Intestinal Mucosa
2
2008
620
0.060
 Why?
Laser Coagulation
1
2006
71
0.060
 Why?
Prosthesis Design
2
2009
333
0.060
 Why?
Tomography, X-Ray Computed
2
2014
2697
0.060
 Why?
Conscious Sedation
1
2006
94
0.060
 Why?
Ascites
1
2005
47
0.060
 Why?
Anesthesia, General
1
2006
117
0.060
 Why?
Thoracic Neoplasms
1
2005
37
0.060
 Why?
Acute Disease
1
2008
994
0.060
 Why?
Administration, Rectal
1
2024
13
0.060
 Why?
Equipment Failure
1
2005
110
0.060
 Why?
Growth Substances
1
2004
148
0.050
 Why?
Pain Management
1
2008
389
0.050
 Why?
Radiotherapy, Adjuvant
3
2013
215
0.050
 Why?
Infant
1
2018
9586
0.050
 Why?
Immunoglobulin A
1
2005
214
0.050
 Why?
Chemotherapy, Adjuvant
3
2013
375
0.050
 Why?
Liver Cirrhosis
1
2006
277
0.050
 Why?
International Cooperation
2
2017
202
0.050
 Why?
Child, Preschool
1
2018
11171
0.050
 Why?
Neoplasm Metastasis
1
2005
667
0.050
 Why?
Diagnostic Tests, Routine
1
2003
109
0.050
 Why?
Pilot Projects
1
2008
1766
0.050
 Why?
Necrosis
1
2023
248
0.050
 Why?
Odds Ratio
2
2016
1084
0.040
 Why?
Combined Modality Therapy
3
2013
1235
0.040
 Why?
Anti-Infective Agents, Local
1
2021
40
0.040
 Why?
Polycystic Kidney, Autosomal Dominant
1
2004
260
0.040
 Why?
Drug Combinations
1
2020
346
0.040
 Why?
Disease-Free Survival
2
2013
704
0.040
 Why?
Double-Blind Method
1
2023
1949
0.040
 Why?
Kaplan-Meier Estimate
2
2013
897
0.040
 Why?
Myotomy
1
2018
15
0.040
 Why?
Endoscopic Mucosal Resection
1
2018
25
0.040
 Why?
Equipment Contamination
1
2018
71
0.030
 Why?
Republic of Korea
1
2017
42
0.030
 Why?
Administration, Oral
1
2020
788
0.030
 Why?
Surgical Instruments
1
2018
50
0.030
 Why?
Bile
2
2009
25
0.030
 Why?
Surgery, Computer-Assisted
1
2018
75
0.030
 Why?
Autopsy
1
2017
97
0.030
 Why?
Prosthesis Failure
2
2009
123
0.030
 Why?
Colonic Polyps
1
2018
83
0.030
 Why?
United Kingdom
1
2017
321
0.030
 Why?
Cytokines
1
2004
2084
0.030
 Why?
Hospitalization
1
2006
2233
0.030
 Why?
Videotape Recording
1
2016
39
0.030
 Why?
Gastroenterologists
1
2016
16
0.030
 Why?
Barrett Esophagus
1
2018
154
0.030
 Why?
Radiologists
1
2016
49
0.030
 Why?
Geriatric Assessment
1
2017
219
0.030
 Why?
Quality Indicators, Health Care
1
2018
308
0.030
 Why?
Watchful Waiting
1
2016
77
0.030
 Why?
Surveys and Questionnaires
1
2008
5887
0.030
 Why?
Phantoms, Imaging
1
2016
144
0.030
 Why?
Disease Management
1
2018
622
0.030
 Why?
Societies, Medical
2
2008
838
0.030
 Why?
Inflammatory Bowel Diseases
1
2018
352
0.030
 Why?
Organoplatinum Compounds
1
2013
48
0.030
 Why?
Leucovorin
1
2013
85
0.020
 Why?
Injections, Intralesional
1
2013
35
0.020
 Why?
Erlotinib Hydrochloride
1
2013
69
0.020
 Why?
Program Evaluation
1
2017
917
0.020
 Why?
Camptothecin
1
2013
122
0.020
 Why?
Comorbidity
1
2017
1658
0.020
 Why?
Treatment Failure
1
2013
351
0.020
 Why?
False Negative Reactions
1
2011
60
0.020
 Why?
Quinazolines
1
2013
249
0.020
 Why?
False Positive Reactions
1
2011
124
0.020
 Why?
Drug Administration Schedule
1
2013
769
0.020
 Why?
Colorectal Neoplasms
1
2018
792
0.020
 Why?
Neoadjuvant Therapy
1
2013
412
0.020
 Why?
Longitudinal Studies
1
2017
2854
0.020
 Why?
Stainless Steel
1
2009
20
0.020
 Why?
Hematoma
1
2009
54
0.020
 Why?
Alloys
1
2009
37
0.020
 Why?
Terminally Ill
1
2009
37
0.020
 Why?
Observer Variation
1
2010
350
0.020
 Why?
Medical Laboratory Science
1
2008
9
0.020
 Why?
Rupture
1
2008
88
0.020
 Why?
Miniaturization
1
2008
22
0.020
 Why?
Ligation
1
2008
93
0.020
 Why?
Capecitabine
1
2008
41
0.020
 Why?
Probability
1
2009
308
0.020
 Why?
Premedication
1
2008
41
0.020
 Why?
Total Quality Management
1
2008
61
0.020
 Why?
Esophageal and Gastric Varices
1
2008
35
0.020
 Why?
Evaluation Studies as Topic
1
2008
175
0.020
 Why?
Forms and Records Control
1
2008
21
0.020
 Why?
Radiotherapy Dosage
1
2008
280
0.020
 Why?
Morbidity
1
2008
321
0.020
 Why?
Remission Induction
1
2008
293
0.020
 Why?
Diarrhea
1
2008
182
0.020
 Why?
Safety Management
1
2008
126
0.020
 Why?
Biopsy, Needle
1
2007
187
0.020
 Why?
Injections
1
2007
190
0.020
 Why?
Costs and Cost Analysis
1
2007
223
0.020
 Why?
DNA
1
2013
1441
0.020
 Why?
Survival Analysis
1
2009
1311
0.020
 Why?
Information Dissemination
1
2008
223
0.010
 Why?
Safety
1
2007
348
0.010
 Why?
Patient Selection
1
2009
680
0.010
 Why?
Prostheses and Implants
1
2006
143
0.010
 Why?
Obesity
1
2018
2995
0.010
 Why?
Receptors, Interleukin-8B
1
2004
26
0.010
 Why?
Survival Rate
1
2008
1936
0.010
 Why?
Recurrence
1
2007
1085
0.010
 Why?
Esophagectomy
1
2005
137
0.010
 Why?
Swine
1
2006
801
0.010
 Why?
Positron-Emission Tomography
1
2005
304
0.010
 Why?
Ischemia
1
2004
414
0.010
 Why?
Epithelial Cells
1
2004
1103
0.010
 Why?
Cells, Cultured
1
2004
4183
0.010
 Why?
Biomarkers
1
2008
4095
0.010
 Why?
Disease Models, Animal
1
2006
4319
0.010
 Why?
Animals
1
2006
37261
0.000
 Why?
Shah's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (348) concept(s)
_
Co-Authors Expand Description
See all (21) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)